Drug Landscape ›
Artificial tears eye-drops ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 5
Most-reported reactions
Cataract — 1 report (20%) Eye Discharge — 1 report (20%) Eye Pain — 1 report (20%) Pancreatic Carcinoma — 1 report (20%) Pancreatitis Acute — 1 report (20%)
Source database →
Artificial tears eye-drops in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Artificial tears eye-drops approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Artificial tears eye-drops in United States?
Hotel Dieu de France Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.